These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21132477)

  • 1. Palonosetron-induced migraine-type headache.
    Jain A
    Can J Anaesth; 2011 Feb; 58(2):230-1. PubMed ID: 21132477
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
    Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
    J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palonosetron. RS 25259, RS 25259 197.
    Drugs R D; 1999 Oct; 2(4):251-2. PubMed ID: 10659403
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged drug-induced myoclonus: is it related to palonosetron?
    Chaw SH; Chan L; Lee PK; Bakar JA; Rasiah R; Foo LL
    J Anesth; 2016 Dec; 30(6):1063-1066. PubMed ID: 27510560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron-induced migraine-type headache.
    Singh V; Sinha A; Prakash N
    Can J Anaesth; 2010 Sep; 57(9):872-3. PubMed ID: 20661681
    [No Abstract]   [Full Text] [Related]  

  • 7. Palonosetron induced anaphylaxis in an adult female.
    Gupta YK; Shanmugam SP; Padhy BM; Goyal A
    Br J Clin Pharmacol; 2010 Jul; 70(1):149-50. PubMed ID: 20642559
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medical treatment of chemotherapy-induced nausea and vomiting].
    Herrstedt J
    Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.
    Kovac AL; Eberhart L; Kotarski J; Clerici G; Apfel C;
    Anesth Analg; 2008 Aug; 107(2):439-44. PubMed ID: 18633021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial.
    Chun HR; Jeon IS; Park SY; Lee SJ; Kang SH; Kim SI
    Br J Anaesth; 2014 Mar; 112(3):485-90. PubMed ID: 24154700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.
    Navari RM
    Future Oncol; 2006 Oct; 2(5):591-602. PubMed ID: 17026451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin-1 and novel serotonin antagonists for postoperative and postdischarge nausea and vomiting.
    George E; Hornuss C; Apfel CC
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):714-21. PubMed ID: 20871394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. We're tired of waiting.
    Lichtor JL; Glass PS
    Anesth Analg; 2008 Aug; 107(2):353-5. PubMed ID: 18633005
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study.
    Moon YE; Joo J; Kim JE; Lee Y
    Br J Anaesth; 2012 Mar; 108(3):417-22. PubMed ID: 22277663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia.
    Kim HJ; Lee HC; Jung YS; Lee J; Min JJ; Hong DM; Choi EK; Oh S; Jeon Y
    Br J Anaesth; 2014 Mar; 112(3):460-8. PubMed ID: 24129597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy.
    Musso M; Scalone R; Bonanno V; Crescimanno A; Polizzi V; Porretto F; Bianchini C; Perrone T
    Support Care Cancer; 2009 Feb; 17(2):205-9. PubMed ID: 18839220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting serotonin antagonist (Palonosetron) and the NK-1 receptor antagonists: does extended duration of action improve efficacy?
    Melton MS; Nielsen KC; Tucker M; Klein SM; Gan TJ
    Anesthesiol Clin; 2014 Jun; 32(2):505-16. PubMed ID: 24882134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.
    Candiotti KA; Kovac AL; Melson TI; Clerici G; Joo Gan T;
    Anesth Analg; 2008 Aug; 107(2):445-51. PubMed ID: 18633022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of palonosetron on postoperative nausea and vomiting in children following dental rehabilitation under general anesthesia.
    Yildirim MD; Cantekin K
    Pediatr Dent; 2014; 36(1):7E-11E. PubMed ID: 24717698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.